AAAAAA
Results:
1-9
|
Results: 9
Authors:
Hecht, HJ
Adar, R
Hofmann, B
Bogin, O
Weich, H
Yayon, A
Citation: Hj. Hecht et al., Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfaces, ACT CRYST D, 57, 2001, pp. 378-384
Authors:
Benenson, Y
Paz-Elizur, T
Adar, R
Keinan, E
Livneh, Z
Shapiro, E
Citation: Y. Benenson et al., Programmable and autonomous computing machine made of biomolecules, NATURE, 414(6862), 2001, pp. 430-434
Authors:
Onaca, N
Hirshberg, A
Adar, R
Citation: N. Onaca et al., Early reoperation for perirectal abscess - A preventable complication, DIS COL REC, 44(10), 2001, pp. 1469-1472
Authors:
Adar, R
Yayon, A
Citation: R. Adar et A. Yayon, Mapping a heparin binding site on ErbB-3 epidermal growth factor receptor, BIOC BIOP R, 283(1), 2001, pp. 1-5
Authors:
Schneiderman, J
Morag, B
Gerniak, A
Rimon, U
Varon, D
Seligsohn, U
Shotan, A
Adar, R
Citation: J. Schneiderman et al., Abciximab in carotid stenting for postsurgical carotid restenosis: Intermediate results, J ENDOVAS T, 7(4), 2000, pp. 263-272
Authors:
Ehrenfeld, M
Adar, R
Citation: M. Ehrenfeld et R. Adar, Rheumatic manifestations in patients with thromboangiitis obliterans (Buerger's disease), J RHEUMATOL, 27(7), 2000, pp. 1818-1818
Authors:
Monsonego-Ornan, E
Adar, R
Feferman, T
Segev, O
Yayon, A
Citation: E. Monsonego-ornan et al., The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation, MOL CELL B, 20(2), 2000, pp. 516-522
Authors:
Adar, R
Papa, MZ
Schneiderman, J
Citation: R. Adar et al., Thromboangiitis obliterans: an old disease in need of a new look, INT J CARD, 75, 2000, pp. S167-S170
Authors:
Chen, L
Adar, R
Yang, X
Monsonego, EO
Li, CL
Hauschka, PV
Yayon, A
Deng, CX
Citation: L. Chen et al., Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis, J CLIN INV, 104(11), 1999, pp. 1517-1525
Risultati:
1-9
|